Long-Term Treatment of Collagenous Colitis With Budesonide

Summary

The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)

Timeline

Start

2004-09

Primary completion

—

Completion

2006-03

Drugs

Indications